BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 6993592)

  • 1. Impaired production of mononuclear cell procoagulant activity in chronic lymphocytic leukaemia.
    Cortellazzo S; Viero P; Barbui T; Colucci M; Semeraro N
    J Clin Pathol; 1983 Jan; 36(1):37-40. PubMed ID: 6337189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Progress in the elucidation of the underlying biochemical defect.
    McKinnon PJ
    Hum Genet; 1987 Mar; 75(3):197-208. PubMed ID: 3549535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on lymphocyte cell surface in ataxia-telangiectasia.
    Ozer NK; Ciliv G; Berkel AI; Sanal O; Yeğin O; Ersoy F
    Clin Exp Immunol; 1985 Jul; 61(1):118-24. PubMed ID: 2994921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T).
    Weisbart RH; Billing R
    Immunology; 1980 Apr; 39(4):577-82. PubMed ID: 6991400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.
    Faguet GB
    J Clin Invest; 1979 Jan; 63(1):67-74. PubMed ID: 153914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells in B cell chronic lymphocytic leukaemia. I. Decreased frequency of T lymphocytes secreting suppressor factor.
    Bloem AC; Clevers JC; Bast EJ; Ballieux RE
    Clin Exp Immunol; 1986 Jan; 63(1):188-93. PubMed ID: 3485483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective specific antiinfluenza virus antibody production in vitro by lymphocytes from patients with ataxia-telangiectasia.
    Yarchoan R; Kurman CC; Nelson DL
    Kroc Found Ser; 1985; 19():315-29. PubMed ID: 3877788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypogammaglobulinaemia associated with abnormalities of both B and T lymphocytes in patients with chronic lymphatic leukaemia.
    Hersey P; Wotherspoon J; Reid G; Gunz FW
    Clin Exp Immunol; 1980 Mar; 39(3):698-707. PubMed ID: 6445798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired cellular interactions involving lymphocytes from patients with chronic lymphocytic leukemia and ataxia-telangiectasia.
    Weisbart RH; Kacena A; Golde DW; Costea NV
    J Lab Clin Med; 1980 Jul; 96(1):114-8. PubMed ID: 6993592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The lymphocyte abnormality in CNS disease].
    Matsubara H; Igata A
    No To Shinkei; 1983 May; 35(5):423-31. PubMed ID: 6354216
    [No Abstract]   [Full Text] [Related]  

  • 11. Inflammatory, non-antibody lymphocytic mediators (lymphokines).
    Bendtzen K; Bendixen G
    Allerg Immunol (Leipz); 1980; 26(4):293-309. PubMed ID: 6163346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-lymphocytes in B-cell chronic lymphocytic leukaemia.
    Foa R; Catovsky D; Lauria F; Zafar MN; Galton DA
    Haematologica; 1981 Feb; 66(1):105-16. PubMed ID: 6785161
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.